title: Doubling back on centromere 17 in early breast cancer.
authors.forename: Philippe L
authors.initials: PL
authors.lastname: Bedard
authors.forename: Christine
authors.initials: C
authors.lastname: Desmedt
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000494:pharmacology*; D000951:Antigens, Neoplasm / Q000235:genetics*; D054316:Biomarkers, Pharmacological; D001943:Breast Neoplasms / Q000188:drug therapy*; D002503:Centromere; D004250:DNA Topoisomerases, Type II / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics*; D015251:Epirubicin / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005784:Gene Amplification; D018734:Genes, erbB-2 / Q000235:genetics*; D006801:Humans
chemical_list: D000903:Antibiotics, Antineoplastic; D000951:Antigens, Neoplasm; D054316:Biomarkers, Pharmacological; D004268:DNA-Binding Proteins; D015251:Epirubicin; D004250:DNA Topoisomerases, Type II